Agios Pharmaceuticals, Inc.
AGIO
$27.42
-$0.07-0.26%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 7.67% | -25.46% | 7.49% | -110.18% | 1,086.20% |
| Total Depreciation and Amortization | 9.13% | -1.49% | -6.51% | 1.64% | -15.57% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -44.23% | 94.62% | 57.90% | 100.76% | -9,234.12% |
| Change in Net Operating Assets | -102.79% | 122.69% | 21.09% | -202.00% | 347.93% |
| Cash from Operations | -14.30% | 30.82% | 16.28% | -58.12% | -16.02% |
| Capital Expenditure | -77.71% | -14.23% | 20.79% | -130.79% | -165.19% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -100.00% | -- |
| Other Investing Activities | 21.63% | -29.56% | 335.22% | -194.10% | 36.92% |
| Cash from Investing | 21.01% | -29.86% | 329.03% | -119.60% | 573.38% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 6,723.08% | -95.99% | -66.56% | 83.62% | 139.95% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 6,723.08% | -95.99% | -66.56% | 83.62% | 139.95% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 520.82% | -29.81% | 101.53% | -204.89% | 594.11% |